Latham & Watkins Advises on Sale of Stake in Fresenius Medical Care by Fresenius
Latham & Watkins LLP has advised the banks on the successful disposal of a stake in Fresenius Medical Care AG by Fresenius SE & Co. KGaA (Fresenius). The transaction involved a sale of existing shares through an accelerated bookbuilding process and the placement of senior unsecured bonds exchangeable into shares of Fresenius Medical Care AG. The combined transaction generates gross proceeds of approximately €1.1 billion for Fresenius.
BofA Securities Europe SA and Goldman Sachs Bank Europe SE acted as joint global coordinators, alongside BNP PARIBAS and Deutsche Bank Aktiengesellschaft as joint bookrunners and Banco Santander, S.A. acted as co-lead manager.
The Latham team was led by Frankfurt capital markets partner Oliver Seiler and counsel Camilla Kehler-Weiß, with London partner Ryan Benedict, Frankfurt partner David Rath, Frankfurt associate Alexandre Maturana, and Milan capital markets lawyer Irene Pistotnik.